GTx-024 as a Treatment for Stress Urinary Incontinence in Women: A Proof of Concept Study

Trial Profile

GTx-024 as a Treatment for Stress Urinary Incontinence in Women: A Proof of Concept Study

Recruiting
Phase of Trial: Phase II

Latest Information Update: 21 Jun 2017

At a glance

  • Drugs Enobosarm (Primary)
  • Indications Urinary incontinence
  • Focus Proof of concept; Therapeutic Use
  • Sponsors GTx
  • Most Recent Events

    • 12 Jun 2017 According to a GTx Media Release, company subsequently added two additional clinical trial sites, and data from additional patients from this study will be predented at the ICS meeting in September.
    • 12 Jun 2017 According to a GTx Media Release, preliminary results from this trial were published at the International Continence Society website.
    • 12 Jun 2017 Preliminary results (n=7) from this trial published in a GTx Media Release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top